Product Information

BETAMETHASONE SP-AC 30 MG/5 ML is a generic product labeled by American Regent, Inc., priced at $9.2627 per ML under NDC 00517079901. Its NADAC has been published 270 times since Jul 29, 2020.

FDA first approved this application on Jul 31, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BETAMETHASONE SP-AC 30 MG/5 ML

Betamethasone Sodium Phosphate and Betamethasone Acetate
$9.2627per ML

Strength

3; 3 mg/mL; mg/mL

NDC

00517079901

Classification

Generic

Dosage Form

INJECTION, SUSPENSION

Route

INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA090747

FDA Approved

7/31/2009

TE Code

AB

On Market Since

11/1/2019

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid
Corticosteroid

Price Statistics

The NADAC for BETAMETHASONE SP-AC 30 MG/5 ML has been published 270 times since Jul 29, 2020, and over the history we have for it it has risen 10.6%. The table below summarizes its recorded NADAC range and movement.

Current price$9.2627 per ML
All-time high$9.4699 (Oct 15, 2025)
All-time low$8.0184 (Nov 23, 2022)
52-week high$9.4699
52-week low$9.1621
Median price$8.6509
Average price$8.6490
Largest weekly change+6.7% (Aug 18, 2021)
Weeks tracked270
Tracking sinceJul 29, 2020

Price History

1W

-1.5%

1M

-1.5%

3M

-2.1%

6M

-1.0%

1Y

-1.2%

3Y

+13.9%

5Y

+3.7%

All

+10.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BETAMETHASONE SP-AC 30 MG/5 ML?

The current National Average Drug Acquisition Cost (NADAC) for BETAMETHASONE SP-AC 30 MG/5 ML, manufactured by American Regent, Inc., is $9.2627 per ML (NDC 00517079901), effective Aug 19, 2026.

How has the price of BETAMETHASONE SP-AC 30 MG/5 ML changed over time?

Over the history we have for it, the NADAC for BETAMETHASONE SP-AC 30 MG/5 ML has risen 10.6%. It has been tracked across 270 weekly CMS publications since Jul 29, 2020.

What are the highest and lowest recorded NADAC prices for BETAMETHASONE SP-AC 30 MG/5 ML?

Since Jul 29, 2020, the NADAC for BETAMETHASONE SP-AC 30 MG/5 ML has ranged from a low of $8.0184 (Nov 23, 2022) to a high of $9.4699 (Oct 15, 2025), with a median of $8.6509 per ML.

Are there cheaper alternatives to BETAMETHASONE SP-AC 30 MG/5 ML?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BETAMETHASONE SP-AC 30 MG/5 ML in a comparable dosage form, but none are currently priced below it.

Who manufactures BETAMETHASONE SP-AC 30 MG/5 ML?

BETAMETHASONE SP-AC 30 MG/5 ML (NDC 00517079901) is labeled by American Regent, Inc., and CMS classifies it as a generic product.